261 related articles for article (PubMed ID: 20236230)
1. Both p110alpha and p110beta isoforms of phosphatidylinositol 3-OH-kinase are required for insulin signalling in the hypothalamus.
Tups A; Anderson GM; Rizwan M; Augustine RA; Chaussade C; Shepherd PR; Grattan DR
J Neuroendocrinol; 2010 Jun; 22(6):534-42. PubMed ID: 20236230
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the kinetic properties of the lipid- and protein-kinase activities of the p110alpha and p110beta catalytic subunits of class-Ia phosphoinositide 3-kinases.
Beeton CA; Chance EM; Foukas LC; Shepherd PR
Biochem J; 2000 Sep; 350 Pt 2(Pt 2):353-9. PubMed ID: 10947948
[TBL] [Abstract][Full Text] [Related]
3. Hypothalamic phosphatidylinositol 3-kinase-phosphodiesterase 3B-cyclic AMP pathway of leptin signalling is impaired following chronic central leptin infusion.
Sahu A; Metlakunta AS
J Neuroendocrinol; 2005 Nov; 17(11):720-6. PubMed ID: 16219000
[TBL] [Abstract][Full Text] [Related]
4. Leptin stimulates alpha1(I) collagen expression in human hepatic stellate cells via the phosphatidylinositol 3-kinase/Akt signalling pathway.
Niu L; Wang X; Li J; Huang Y; Yang Z; Chen F; Ni H; Jin Y; Lu X; Cao Q
Liver Int; 2007 Nov; 27(9):1265-72. PubMed ID: 17919239
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiation.
Billottet C; Banerjee L; Vanhaesebroeck B; Khwaja A
Cancer Res; 2009 Feb; 69(3):1027-36. PubMed ID: 19176369
[TBL] [Abstract][Full Text] [Related]
6. PI3K integrates the effects of insulin and leptin on large-conductance Ca2+-activated K+ channels in neuropeptide Y neurons of the hypothalamic arcuate nucleus.
Yang MJ; Wang F; Wang JH; Wu WN; Hu ZL; Cheng J; Yu DF; Long LH; Fu H; Xie N; Chen JG
Am J Physiol Endocrinol Metab; 2010 Feb; 298(2):E193-201. PubMed ID: 19671839
[TBL] [Abstract][Full Text] [Related]
7. The role of PI 3-kinase p110beta in AKT signally, cell survival, and proliferation in human prostate cancer cells.
Hill KM; Kalifa S; Das JR; Bhatti T; Gay M; Williams D; Taliferro-Smith L; De Marzo AM
Prostate; 2010 May; 70(7):755-64. PubMed ID: 20058239
[TBL] [Abstract][Full Text] [Related]
8. Targeting the PI3K p110alpha isoform inhibits medulloblastoma proliferation, chemoresistance, and migration.
Guerreiro AS; Fattet S; Fischer B; Shalaby T; Jackson SP; Schoenwaelder SM; Grotzer MA; Delattre O; Arcaro A
Clin Cancer Res; 2008 Nov; 14(21):6761-9. PubMed ID: 18980969
[TBL] [Abstract][Full Text] [Related]
9. Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling.
Chaussade C; Rewcastle GW; Kendall JD; Denny WA; Cho K; Grønning LM; Chong ML; Anagnostou SH; Jackson SP; Daniele N; Shepherd PR
Biochem J; 2007 Jun; 404(3):449-58. PubMed ID: 17362206
[TBL] [Abstract][Full Text] [Related]
10. Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection.
Davidson SM; Hausenloy D; Duchen MR; Yellon DM
Int J Biochem Cell Biol; 2006 Mar; 38(3):414-9. PubMed ID: 16280253
[TBL] [Abstract][Full Text] [Related]
11. Activation of phosphatidylinositol 3-kinase and protein kinase B/Akt in dorsal root ganglia and spinal cord contributes to the neuropathic pain induced by spinal nerve ligation in rats.
Xu JT; Tu HY; Xin WJ; Liu XG; Zhang GH; Zhai CH
Exp Neurol; 2007 Aug; 206(2):269-79. PubMed ID: 17628541
[TBL] [Abstract][Full Text] [Related]
12. Involvement of PI3-kinase and its association with c-Src in PTH-stimulated rat enterocytes.
Gentili C; Morelli S; Russo De Boland A
J Cell Biochem; 2002; 86(4):773-83. PubMed ID: 12210743
[TBL] [Abstract][Full Text] [Related]
13. Role of PI3K and PKB/Akt in acute natriuretic and NO-mimetic effects of leptin.
Bełtowski J; Wójcicka G; Jamroz-Wiśniewska A; Borkowska E
Regul Pept; 2007 May; 140(3):168-77. PubMed ID: 17229473
[TBL] [Abstract][Full Text] [Related]
14. WJD008, a dual phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin inhibitor, prevents PI3K signaling and inhibits the proliferation of transformed cells with oncogenic PI3K mutant.
Li T; Wang J; Wang X; Yang N; Chen SM; Tong LJ; Yang CH; Meng LH; Ding J
J Pharmacol Exp Ther; 2010 Sep; 334(3):830-8. PubMed ID: 20522531
[TBL] [Abstract][Full Text] [Related]
15. The role of phosphoinositide-3-kinase/Akt pathway in propofol-induced postconditioning against focal cerebral ischemia-reperfusion injury in rats.
Wang HY; Wang GL; Yu YH; Wang Y
Brain Res; 2009 Nov; 1297():177-84. PubMed ID: 19703434
[TBL] [Abstract][Full Text] [Related]
16. Leptin induces IL-8 expression via leptin receptor, IRS-1, PI3K, Akt cascade and promotion of NF-kappaB/p300 binding in human synovial fibroblasts.
Tong KM; Shieh DC; Chen CP; Tzeng CY; Wang SP; Huang KC; Chiu YC; Fong YC; Tang CH
Cell Signal; 2008 Aug; 20(8):1478-88. PubMed ID: 18501560
[TBL] [Abstract][Full Text] [Related]
17. A specific function for phosphatidylinositol 3-kinase alpha (p85alpha-p110alpha) in cell survival and for phosphatidylinositol 3-kinase beta (p85alpha-p110beta) in de novo DNA synthesis of human colon carcinoma cells.
Bénistant C; Chapuis H; Roche S
Oncogene; 2000 Oct; 19(44):5083-90. PubMed ID: 11042696
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the catalytic subunit of class IA PI3K confer leukemogenic potential to hematopoietic cells.
Horn S; Bergholz U; Jücker M; McCubrey JA; Trümper L; Stocking C; Bäsecke J
Oncogene; 2008 Jul; 27(29):4096-106. PubMed ID: 18317450
[TBL] [Abstract][Full Text] [Related]
19. Dominant role of the p110beta isoform of PI3K over p110alpha in energy homeostasis regulation by POMC and AgRP neurons.
Al-Qassab H; Smith MA; Irvine EE; Guillermet-Guibert J; Claret M; Choudhury AI; Selman C; Piipari K; Clements M; Lingard S; Chandarana K; Bell JD; Barsh GS; Smith AJ; Batterham RL; Ashford ML; Vanhaesebroeck B; Withers DJ
Cell Metab; 2009 Nov; 10(5):343-54. PubMed ID: 19883613
[TBL] [Abstract][Full Text] [Related]
20. Dominant Role of PI3K p110α over p110β in Insulin and β-Adrenergic Receptor Signalling.
Zhang B; Luk C; Valadares J; Aronis C; Foukas LC
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
